The W.H.O. rejects the antiviral drug remdesivir as a Covid-19 treatment.
Published
Published
WASHINGTON (AP) — The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans..
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU), a biotech company focused on interferon (IFN) based therapeutics,..
The antiviral drug remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of..